Towards a philosophy of public health

Journal of Epidemiology and Community Health

Volumn 53, Issue 2, 1999, Pages 99-104

  Weed, Douglas L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; ETHICS; PHILOSOPHY; PUBLIC HEALTH; REVIEW; THEORY;

EID: 0032896764     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.53.2.99     Document Type: Review

References (48)

1. Nijhuis HG, Van der Maesen LJG. The philosophical foundations of public health: an invitation to debate. J Epidemiol Community Health 1994;48:1-3.
2. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985;14:32-8.
3. Terris M. The Society of Epidemiologic Research (SER) and the future of epidemiology. Am J Epidemiol 1992;136: 909-15.
4. Weed DL. Epidemiology, the humanities, and public health. Am J Public Health 1995;85:914-18.
5. Shy CM. The failure of academic epidemiology: witness for the prosecution. Am J Epidemiol 1997;145:479-86.
6. Rose G. Strategy of prevention: lessons from cardiovascular disease. BMJ 1981;282:1849-51.
7. Marteau TM. Reducing the psychological costs. BMJ 1990; 301:26-8.
8. Riis P. Mass screening procedures and programmes. In: Doxiadis S, ed. Ethical dilemmas in health promotion. New York: Wiley, 1987:171-82.
9. Beauchamp DE. Philosophy of public health. In: Reich WT, ed. Encylopedia of bioethics. New York: Simon and Schuster MacMillan, 1995:2161-6.
10. O'Hagan J. The ethics of informed consent in relation to prevention screening programmes. NZ Med J 1991;104: 121-3.
11. Cole P. The moral bases for public health interventions. Epidemiology 1994;6:78-83.
12. Pellegrino ED. Autonomy and coercion in disease prevention and health promotion. Theor Med 1984;5:83-91.
13. Last JM. Ethics and public health policy. In: Last JM, Wallace RB, eds. Public health and preventive medicine. Norwalk: Appleton and Lange, 1992:1187-96.
14. Weed DL. Epistemology and ethics in epidemiology. In: Coughlin SS, Beauchamp TL, eds. Ethics and epidemiology. New York: Oxford University Press, 1996:76-94.
15. Mandelson MT, Wagenr EH, Thompson RS. PSA screening: a public health dilemma. Annu Rev Public Health 1995;16:283-306.
16. Schroder FH. Prostate cancer: to screen or not to screen? BMJ 1993;306:407-8.
17. Catalona WJ. Screening for prostate cancer: enthusiasm. Urology 1993;42:113-15.
18. Kramer BS, Gohagan JK, Prorok PC. Is screening for prostate cancer the current gold standard? - No. Eur J Cancer 1997;33:348-53.
19. Lange PH. Is screening for prostate cancer the current gold standard? - Yes. Eur J Cancer 1997;33:354-6.
20. Gohagan JK, Prorok PC, Kramer BS, et al. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. J Urol 1994;152:1905-9.
21. Schroder FH, Bangma CH. The European randomized study of screening for prostate cancer (ERSPC). Br J Urol 1997;79 (suppl 1):68-71.
22. Wilt TJ, Brawer MK. The prostate cancer intervention versus observation trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol 1994;152:1910-14.
23. Voss JD. Prostate cancer: screening and prostate-specific antigen: promise or peril? J Gen Intern Med 1994;9:468-74.
24. Middleton RG. Prostate cancer: are we screening and treating too much? Ann Intern Med 1997;126:465-7.
25. Vineis P. Proof in observational medicine. J Epidemiol Commun Health 1997;51:9-13.
26. Mettlin C, Jones G, Averette H, et al. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin 1993;43:42-6.
27. Chodak GW. Questioning the value of screening for prostate cancer in asymptomatic men. Urology 1993;42:116-18.
28. Woolf SH. Public health perspective: the healthy policy implications of screening for prostate cancer. J Urol 1994;152:1685-8.
29. Woolf SH. Should we screen for prostate cancer? BMJ 1997;314:989-90.
30. Hahn DL, Roberts RG. PSA screening for asymptomatic prostate cancer: truth in advertising. J Fam Pract 1993;37: 432-4.
31. Wolf AMD, Nasser JF, Wolf A, et al. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med 1996;156:1333-6.
32. Aronowitz R. To screen or not to screen: what is the question? J Gen Intern Med 1995;10:295-7.
33. Pellegrino ED, Hart RJ, Henderson S, et al. Relevance and utility of courses in medical ethics: a survey of physicians' perceptions. JAMA 1985;253:72-86.
34. Self DJ, Wolinsky FD, Baldwin DC. The effect of teaching medical ethics on medical students' moral reasoning. Acad Med 1989;64:755-9.
35. Schlesinger GN. Scientists and philosophy. In: Rothman KJ, ed. Causal inference. Chestnut Hill, MA: ERI, 1988:77-91.
36. Weed DL. Underdetermination and incommensurability in contemporary epidemiology. Kennedy Institute of Ethics Journal 1997;7:107-27.
37. Longino HE. Science as social knowledge. Princeton, NJ: University Press, 1990.
38. Skrabanek P. Why is preventive medicine exempted from ethical constraints? J Med Ethics 1990;16:187-90.
39. Gillon R. Ethics in health promotion and prevention of disease. J Med Ethics 1990;16:171-2.
40. Horner JS. Medical ethics and the public health. Public Health 1992;106:185-92.
41. Adami HO, Baron JA, Rothman KJ. Ethics of a prostate cancer screening trial. Lancet 1994;343:958-60.
42. Mant D, Fowler G. Mass screening: theory and ethics. BMJ 1990;300:916-18.
43. Wald N, Law M. Screening, ethics, and the law. BMJ 1992; 305:892.
44. Welch HG. Questions about the value of early intervention. N Engl J Med 1996;334:1472-3.
45. Edwards PJ, Hall DMB. Screening, ethics, and the law. BMJ 1992;305:267-8.
46. Holland WW. Screening: reasons to be cautious. BMJ 1993; 306:1222-3.
47. Weed DL. Beyond black box epidemiology. Am J Public Health 1998;88:12-14.
48. Pellegrino ED. Philosophy of medicine: towards a definition. J Med Philos 1986;11:9-16.